These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 10877516

  • 1. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
    Cazzola M, Di Perna F, Boveri B, Di Marco F, Diamare F, Centanni S.
    J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516
    [Abstract] [Full Text] [Related]

  • 2. Cefaclor AF: correlation of microbiology and clinical outcome.
    Thornsberry C.
    Postgrad Med J; 1992 Jun; 68 Suppl 3():S10-6. PubMed ID: 1287612
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens.
    Owens RC, Tessier P, Nightingale CH, Ambrose PG, Quintiliani R, Nicolau DP.
    Int J Antimicrob Agents; 2001 Jun; 17(6):483-9. PubMed ID: 11397619
    [Abstract] [Full Text] [Related]

  • 4. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A, Longest KA, Senetar JE, Dere WH.
    Postgrad Med J; 1992 Jun; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [Abstract] [Full Text] [Related]

  • 5. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis.
    Grossman RF.
    Postgrad Med J; 1992 Jun; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antibiotic treatment failures in acute otitis media.
    Stotka JL.
    Pediatr Ann; 1992 May; 21(5):272-5. PubMed ID: 1625940
    [No Abstract] [Full Text] [Related]

  • 10. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA, Farrell DJ, Sader HS, Jones RN.
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
    DeAbate CA, Henry D, Bensch G, Jubran A, Chodosh S, Harper L, Tipping D, Talbot GH.
    Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of acute bacterial bronchitis and pneumonia with cefaclor.
    Mogabgab WJ, Pollock B, Beville RB, Gentry LO, Jemsek JG.
    Postgrad Med J; 1979 Mar; 55 Suppl 4():62-6. PubMed ID: 44908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.